ELANIX BIOTECHNOLOGIES AG
EQS-Ad-hoc: Elanix Biotechnologies AG / Key word(s): Personnel/Personnel ELANIX BIOTECHNOLOGIES AG: RESIGNATION AND NOMINATION IN THE SUPERVISORY BOARD
Frankfurt, Feb 10, 2023 – The Chairman of the Supervisory Board of Elanix Biotechnologies AG (“Company”, “Elanix”) Marco Christen notified the CEO that Yves Bonnard resigned from the Supervisory Board due to work commitments. The Management Board would like to thank Yves Bonnard for his engagement for the Supervisory Board.
The District Court in Berlin has appointed successors, following the Board’s proposal of one suitable candidate.
The Supervisory Board of Elanix Biotechnologies AG (“Company”, “Elanix”) has nominated by juridical order Jean-Frederic Berthoud to become member of the Supervisory Board with immediate effect.
Today, the Elanix Supervisory Board Marco Christen as Chairman of the Board and Murielle Michetti as Vice Chairman appointed and welcomed Jean-Frédéric Berthoud as a new member of the Supervisory Board. Mr. Berthoud, as a retired director of the Department of Economy of the Canton of Vaud, will be a valuable asset for the strategic development of Elanix.
Lee-Ann Laurent-Applegate Interim CEO
14-Feb-2023 CET/CEST The EQS Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases. |
| Language: | English |
| Company: | Elanix Biotechnologies AG |
| Hanauer Landstrasse 291 B | |
| 60314 Frankfurt am Main | |
| Germany | |
| Internet: | https://www.elanixbiotechnologies.ch/ |
| ISIN: | DE000A0WMJQ4 |
| WKN: | A0WMJQ |
| Listed: | Regulated Market in Frankfurt (General Standard); Regulated Unofficial Market in Berlin, Dusseldorf, Munich, Stuttgart, Tradegate Exchange |
| EQS News ID: | 1558785 |
| End of Announcement | EQS News Service |
1558785 14-Feb-2023 CET/CEST
